Follow us:

Microsoft Pri0

Welcome to Microsoft Pri0: That's Microspeak for top priority, and that's the news and observations you'll find here from Seattle Times technology reporter Matt Day.

March 7, 2006 at 3:26 PM

As high as an elephant’s eye

Eden Biosciences saw its stock grow like pumped-up corn after it announced data from a study of its protein supplement, ProAct.

Shares were up 19.2 percent, or 14 cents, to close at 87 cents in heavy trading today.

The Bothell company said ProAct, a protein product applied to crops at the same time as herbicides, increased field-corn yields by an average of 7 bushels per acre in a study done in partnership with the National Corn Growers Association last year.

The association projected a national average yield of 148.4 bushels per acre in 2005.

ProAct works by simulating an attack from a harmful bacteria, tricking the plant into increasing its growth and defense systems.

Eden CFO Brad Powell said farmers who used ProAct returned about five times their investment in the product, which costs around $5 per acre.

The data from the study will bolster Eden’s marketing efforts, Powell said.

Comments | More in Biotechnology

COMMENTS

No personal attacks or insults, no hate speech, no profanity. Please keep the conversation civil and help us moderate this thread by reporting any abuse. See our Commenting FAQ.



The opinions expressed in reader comments are those of the author only, and do not reflect the opinions of The Seattle Times.


The Seattle Times

The door is closed, but it's not locked.

Take a minute to subscribe and continue to enjoy The Seattle Times for as little as 99 cents a week.

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited seattletimes.com content access is included with most subscriptions.

Subscriber login ►
The Seattle Times

To keep reading, you need a subscription upgrade.

We hope you have enjoyed your complimentary access. For unlimited seattletimes.com access, please upgrade your digital subscription.

Call customer service at 1.800.542.0820 for assistance with your upgrade or questions about your subscriber status.

The Seattle Times

To keep reading, you need a subscription.

We hope you have enjoyed your complimentary access. Subscribe now for unlimited access!

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited seattletimes.com content access is included with most subscriptions.

Activate Subscriber Account ►